A Trace ‘Tides Primer: Understanding delta sleep-inducing peptide and the history behind its name

By: Laura Mildon

DSIP stands for delta sleep-inducing peptide. It is a peptide composed of nine amino acids, making it a nonapeptide. Also known as emideltide, DSIP has a long research history involving chemical characterization and the study of electrical brain activity. Its name reflects that history and should not be interpreted as an established benefit of a research product.

Chemical identity

These values describe the parent peptide with an unmodified amino terminus and a carboxylic acid terminus. A salt form, such as an acetate-containing material, requires its own identification. A short product name alone does not establish the exact chemical composition.

PubChem chemical identity and full molecular structure

What does delta mean in the name

Delta refers to a slow-frequency pattern measured in an electroencephalogram, or EEG—a recording of electrical brain activity. In early rabbit experiments, researchers reported changes in delta activity and another EEG pattern called spindle activity. Those observations helped give DSIP its name.

An EEG observation is a measurement in a specific experimental setting. It does not, by itself, establish a complete mechanism or a predictable effect across other settings.

Original characterization by Schoenenberger and Monnier in 1977

History and origins

DSIP’s history traces to the Schoenenberger–Monnier research group in Basel, Switzerland. Researchers investigated whether material collected from rabbit cerebral venous blood during electrically induced experimental sleep contained a peptide associated with their EEG observations.

A key characterization paper appeared in March 1977. A more detailed 1978 publication described amino acid analysis, sequence determination, and synthesis. These papers document the isolation and characterization work; they do not establish one precise date for the initial discovery.

Detailed sequence and synthesis study published in 1978

Selected published research

The following papers offer starting points for understanding DSIP’s chemical history and research limitations. They do not establish an intended application for a commercially supplied research material.

Initial characterization in 1977

Schoenenberger and Monnier reported the nine-amino-acid sequence and compared synthetic DSIP with related peptides in rabbit experiments. The work linked a defined sequence with EEG observations under the conditions studied. Its significance is historical and experimental, rather than proof of a general product benefit.

Read the original paper in Proceedings of the National Academy of Sciences

Biochemical breakdown in 1978

Huang and Lajtha examined DSIP degradation in rat brain homogenates—tissue preparations used for laboratory analysis—and compared it with another peptide, Met-enkephalin. They measured the release of amino acids during breakdown. This work concerns peptide stability in that preparation; it does not establish stability in other environments.

Read the original biochemical study

Antibody recognition and sequence identity in 1993

Researchers isolated a 77-amino-acid peptide from porcine brain that was recognized by an antiserum against DSIP. However, its amino acid sequence was unrelated to DSIP’s sequence. The finding illustrates why antibody recognition alone cannot confirm that a sample contains the exact DSIP nonapeptide.

Read the original peptide-identification study

What remains unresolved

Identifying a synthetic peptide is different from establishing its natural biological origin or mechanism. A 2006 review by Kovalzon and Strekalova highlighted unresolved questions about DSIP’s precursor, a specific receptor, and the identity of naturally occurring material described as “DSIP-like.” The review also discussed inconsistent experimental findings.

“DSIP-like immunoreactivity” means that material reacts with an antibody used to detect DSIP. It does not necessarily establish an identical amino acid sequence. Chemical sequencing and antibody detection answer different questions, so reports using these methods need careful interpretation.

Read the critical review in Journal of Neurochemistry

Regulatory context

DSIP is not an FDA-approved drug. FDA’s July 2026 scientific presentation states that neither emideltide’s parent form nor its acetate form is a component of an FDA-approved drug. It also identifies insufficient safety characterization and concerns involving peptide-related impurities and potential immune responses.

A published study, database entry, or compounding review does not constitute FDA approval of a research product.

FDA scientific presentation on emideltide and related substances

Research and regulatory sources checked October 13, 2026.

DISCLAIMER: These statements are for research purposes only and have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Why choose Trace 'Tides? 

Because trust starts with real people, clear answers, and quality you can verify. We have a certified peptide specialist on staff, a phone number that connects you with a real human, and a physical location you can visit by appointment. Call or text us—we’re delighted to answer your questions and address your concerns. We also make checkout straightforward by accepting credit cards, without asking you to use cryptocurrency or connect your bank account to an unfamiliar payment app. And every peptide we sell is tested for purity and endotoxins by licensed U.S. laboratories, so you can choose your research peptides with confidence.